Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

AI987662 Activators

The term AI987662 Activators likely refers to a group of compounds that can specifically activate a biological or chemical entity denoted as AI987662. The identification and characterization of such activators would involve a series of methodical approaches. Typically, the process begins with high-throughput screening (HTS), wherein a large library of chemicals is tested for an ability to activate the AI987662 entity. This screening can be facilitated by using reporter assays, wherein a detectable signal, such as luminescence or fluorescence, is produced in response to the activation of AI987662. Compounds that result in a significant increase in the reporter signal are identified as potential activators. Subsequent to HTS, these compounds undergo further validation assays to confirm their activity. This may include dose-response experiments to determine the concentration at which the compound is most effective in activating AI987662.

Following the initial discovery phase, detailed investigations are performed to elucidate the mechanisms by which these activators interact with AI987662. This could involve a combination of biophysical techniques such as X-ray crystallography or cryo-electron microscopy, which can provide high-resolution structural details of the AI987662 in complex with the activator. Binding studies, possibly utilizing surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC), can offer quantitative data on the binding affinity and kinetics. Additionally, structure-activity relationship (SAR) studies are conducted to understand how different chemical modifications of the activators affect their ability to activate AI987662. Through SAR studies, the essential chemical features required for activation can be pinpointed, leading to the optimization of the activator compounds. Mutagenesis experiments might also be employed, especially if AI987662 is a protein, to identify the critical regions necessary for the interaction and activation by the compounds. These comprehensive analyses contribute to a clearer understanding of the relationship between the structure of the activators and their activation function, laying the groundwork for further characterization and classification of the compounds within the AI987662 Activators group.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin activates adenylyl cyclase, consequently increasing levels of cyclic AMP (cAMP) in cells. Elevated cAMP can activate PKA which may phosphorylate and enhance the function of AI987662 if it is a substrate for PKA.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates protein kinase C (PKC) which can phosphorylate a range of substrates that could include AI987662, thereby enhancing its activity if AI987662 is part of a pathway downstream of PKC.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

This lipid signaling molecule activates sphingosine-1-phosphate receptors, potentially leading to downstream activation of AI987662 if it is involved in pathways regulated by these receptors.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

Epigallocatechin gallate is known to inhibit several protein kinases, potentially altering signaling pathways and indirectly enhancing the activity of AI987662 if it is negatively regulated by these kinases.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent proteins and pathways that include AI987662, thus enhancing its activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that could lead to the activation of AI987662 by altering the PI3K/AKT pathway, which has numerous downstream effects, including the modulation of proteins involved in this signaling route.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 is a MEK inhibitor that may shift the balance of MAPK pathway signaling, which could enhance the activity of AI987662 if it is regulated by MAPK-dependent phosphorylation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor that could indirectly activate AI987662 by inhibiting p38 MAPK and shifting signaling toward pathways in which AI987662 is involved.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein acts as a tyrosine kinase inhibitor, and by inhibiting competitive signaling pathways, it may enhance the functional activity of AI987662 if tyrosine kinase signaling negatively regulates AI987662.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin disrupts calcium homeostasis by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), potentially leading to the activation of AI987662 through calcium-dependent signaling pathways.